Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $9.4500 (-1.77%) ($9.3200 - $9.8300) on Wed. Jan. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.76% (three month average) | RSI | 58 | Latest Price | $9.4500(-1.77%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | IOVA advances 6.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(48%) IWO(43%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -2.88% in a week (0% probabilities). VXX(-13%) VIXM(-9%) UUP(-7%) DIA(-6%) TLT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.88% (StdDev 5.76%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $9.4(0.53%) | 10 Day Moving Average | $9.22(2.49%) | 20 Day Moving Average | $9.09(3.96%) | To recent high | -20.8% | To recent low | 25.8% | Market Cap | $1.384b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |